Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy
Circulation · 24.06.2025 · 151 (25) · 1767-1779
DOI: 10.1161/circulationaha.124.071980 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Circulation, erschienen am 24.06.2025. Verfasst von Pernille G Thrane und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Aarhus University Hospital, Denmark (P.G.T., M. Maeng, H.E.B.). Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Plaque, Atherosclerotic, Non-ST Elevated Myocardial Infarction, Coronary Artery Disease. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Clinical guidelines recommend different revascularization strategies for nonculprit lesions in patients with ST-segment–elevation myocardial infarction (STEMI) versus non-STEMI (NSTEMI). Whether the prevalence of untreated high-risk vulnerable plaques differs in STEMI and NSTEMI and affects their outcomes is unknown. METHODS: In PROSPECT II (Providing Regional Observations to Study Predictors of Events in the Coronary Tree II), a multicenter, prospective natural history study, patients with recent myocardial infarction underwent 3-vessel coronary angiography with coregistered near-infrared spectroscopy and intravascular ultrasound after successful percutaneous coronary intervention of obstructive lesions from 2014 through 2017. Two-feature high-risk plaques were defined as those with both plaque burden ≥70% and maximum lipid core burden index over any 4-mm segment ≥324.7. The primary end point was major adverse cardiovascular events arising from untreated nonculprit lesions during a median 3.7-year follow-up. RESULTS: Of 898 patients, 199 (22.2%) with 849 nonculprit lesions had STEMI and 699 (77.8%) with 2784 nonculprit lesions had NSTEMI. By intravascular ultrasound, the median nonculprit lesion length was 17.4 mm (interquartile range, 16.3–18.5) in STEMI and 17.7 mm (interquartile range, 17.1–18.4) in NSTEMI ( P =0.63), and the median minimal lumen area was 5.5 mm 2 (interquartile range, 5.3–5.7 mm 2 ) in STEMI and 5.5 mm 2 (interquartile range, 5.3–5.6 mm 2 ) in NSTEMI ( P =0.99). At the lesion level, the prevalence of 2-feature high-risk nonobstructive nonculprit plaques was slightly higher in patients with STEMI than in patients with NSTEMI (12.8% versus 10.1%; P =0.03). At the patient level, however, the prevalence of 2-feature high-risk plaques was similar in STEMI versus NSTEMI (38.8% versus 32.7%; P =0.11). The prevalence of patients with 1 or more lesions meeting at least 1 high-risk plaque criterion was also similar (plaque burden ≥70%, 63.3% versus 57.8% [ P =0.16]; maximum lipid core burden index over any 4-mm segment ≥324.7, 63.3% versus 57.6% [ P =0.15]). The 4-year rates of nonculprit lesion–related major adverse cardiovascular events were similar in STEMI versus NSTEMI (8.6% versus 7.8%; hazard ratio, 1.02 [95% CI, 0.57–1.81]; P =0.95), as were the rates of all major adverse cardiovascular events (14.2% versus 13.0%; hazard ratio, 1.06 [95% CI, 0.68–1.64]; P =0.80). CONCLUSIONS: In the PROSPECT II study, the per-patient prevalence of high-risk vulnerable plaques was comparable in STEMI versus NSTEMI, as was the overall long-term incidence of nonculprit lesion–related and all major adverse cardiovascular events. These results support a similar revascularization strategy for nonculprit lesions in patients with STEMI or NSTEMI after culprit lesion management. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02171065.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Aarhus University Hospital, Denmark (P.G.T., M. Maeng, H.E.B.).
- Department of Clinical Medicine, Aarhus University, Denmark (P.G.T., M. Maeng, H.E.B., O.F.).
- New York-Presbyterian Hospital and Division of Cardiology, Columbia University Irving Medical Center, New York (A.M., Z.A.A.).
- Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (A.M., G.S.M., M. Matsumura, L.N.K.).
- Department of Cardiology, Zealand University Hospital, Roskilde, Denmark (L.K.-H.).
- Department of Cardiology, Rigshospitalet, University of Copenhagen, Denmark (T.E.).
ORCID-Profile: Pernille G Thrane, Michael Maeng, Akiko Maehara, Hans Erik Bøtker, Gary S Mintz, Lars Kjøller-Hansen, Thomas Engstrøm, Mitsuaki Matsumura, Ole Fröbert, Jonas Persson, Rune Wiseth, Alf I Larsen, Lisette O Jensen, Øyvind Bleie, Claes Held, Stefan K James, Ziad A Ali, David Erlinge, Gregg W Stone
Zitieren
APA
Thrane, P. G., Maeng, M., Maehara, A., Bøtker, H. E., Mintz, G. S., Kjøller-Hansen, L., Engstrøm, T., Matsumura, M., Kotinkaduwa, L. N., Fröbert, O., Persson, J., Wiseth, R., Larsen, A. I., Jensen, L. O., Nordrehaug, J. E., Bleie, Ø., Held, C., James, S. K., Ali, Z. A., …, & Stone, G. W. (2025). Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy. Circulation, 151(25), 1767-1779. https://doi.org/10.1161/circulationaha.124.071980
Vancouver
Thrane PG, Maeng M, Maehara A, Bøtker HE, Mintz GS, Kjøller-Hansen L, et al. Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy. Circulation. 2025;151(25):1767-1779. doi:10.1161/circulationaha.124.071980
BibTeX
@article{Thrane2025,
author = {Thrane, Pernille G and Maeng, Michael and Maehara, Akiko and Bøtker, Hans Erik and Mintz, Gary S and Kjøller-Hansen, Lars and Engstrøm, Thomas and Matsumura, Mitsuaki and Kotinkaduwa, Lak N and Fröbert, Ole and Persson, Jonas and Wiseth, Rune and Larsen, Alf I and Jensen, Lisette O and Nordrehaug, Jan E and Bleie, Øyvind and Held, Claes and James, Stefan K and Ali, Ziad A and Erlinge, David and Stone, Gregg W},
title = {Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy},
journal = {Circulation},
year = {2025},
volume = {151},
number = {25},
pages = {1767--1779},
doi = {10.1161/circulationaha.124.071980}
}
EUVIMED